Medical device company Lucid Inc., which raised concern about the company’s future, is exploring strategic alternatives, including a possible private equity investment.

The Rochester, N.Y.-based company incurred net losses of about $4.2 million for the nine months ended Sept. 30, down from an $8.8 million loss the company sustained for the first nine months of 2012. Lucid had an accumulated stockholders’ deficit of about $10.6 million as of Sept. 30.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.